Maluba, Junisa L.
HRN: 24-18-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/30/2023
12/07/2023
IVTT
2.25grams
Q6h
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes